Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease

Area of Science:

• Cellular Biology
• Neuroscience
• Biochemistry

Background:

• Mitochondria are vital for cellular energy and viability, regulating processes through dynamics (fission/fusion) and mitophagy.
• Mitochondrial dysfunction, including oxidative stress and impaired dynamics, is increasingly implicated in Alzheimer's disease (AD) pathogenesis.
• Dysfunctional mitochondria contribute to AD through excessive ROS production, calcium dyshomeostasis, ATP loss, and impaired transport and mitophagy.

Purpose of the Study:

• To review recent advancements in understanding mitochondrial dysfunction in Alzheimer's disease.
• To highlight the critical role of oxidative stress and mitochondrial alterations in AD.
• To discuss current and potential therapeutic strategies targeting mitochondrial function for AD.

Main Methods:

• Literature review of recent research on mitochondrial function and Alzheimer's disease.
• Analysis of studies investigating mitochondrial dynamics, mitophagy, and oxidative stress in AD.
• Synthesis of findings on therapeutic interventions aimed at restoring mitochondrial health.

Main Results:

• Significant evidence links mitochondrial dysfunction, including impaired dynamics and mitophagy, to AD development.
• Oxidative stress and altered mitochondrial Ca2+ handling are prominent features in AD pathogenesis.
• Interventions like exercise, antioxidants, and targeted therapies show promise in mitigating AD progression by improving mitochondrial function.

Conclusions:

• Mitochondrial dysfunction and oxidative stress are central to Alzheimer's disease pathogenesis.
• Therapeutic strategies focused on enhancing mitochondrial function, dynamics, and mitophagy are promising for AD treatment.
• Further research into mitochondrial-targeted therapies could offer new avenues for delaying AD onset and progression.